Hyperpigmentation associated with minocycline therapy.
Chatterjee
Soumya
S
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000009:adverse effects*; D045743:Scleroderma, Diffuse / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D008911:Minocycline